-
2024-517031-51-00
7
Heart Failure
-
2024-519638-22-00
5
IgA nephropathy
-
2025-522001-38-00
4
2026-05-27
Crohn’s Disease
-
2025-521884-12-00
5
2026-03-19
First line triple-negative breast cancer (TNBC)
-
2024-513911-28-00
10
2026-03-04
Acute Ischemic Stroke
-
2024-519706-13-00
6
2026-01-26
Patients with Stable or Unstable coronary syndromes who have undergone
-
2024-513317-12-00
5
2025-02-05
Pancreatic cancer
-
2023-508304-38-00
4
2024-09-10
Ulcerative Colitis (UC)
-
2022-501606-35-01
11
2024-02-21
Platinum-sensitive epithelial ovarian, fallopian tube, or primary
peri
-
2022-500273-14-00
10
2023-07-17
Atherosclerotic cardiovascular disease in patients with ESKD
-
2024-512119-34-00
4
2022-06-20
MSI-H/dMMR metastatic colorectal cancer
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2025-520672-26-00
9
2025-09-16
Gastrointestinal Neoplasms
-
2024-516020-33-00
4
2025-06-26
Grave’s Disease
-
2023-509391-42-00
11
2025-06-02
Chron's Disease
-
2024-513441-36-00
4
2024-11-27
MMRp/ MSS colon cancer
-
2024-513009-30-00
4
2024-11-21
Moderate to Severe Crohn’s Disease
-
2024-515883-30-00
6
2024-08-01
St-Elevated Myocardial Infartion
-
2023-509096-16-00
6
2024-07-31
Moderately to Severely Active Crohn’s Disease
-
2023-505028-74-00
5
2024-01-29
Coronary artery disease
-
2023-506638-59-01
6
2024-01-09
Rheumatoid arthritis